Marc Scheineson comments on the U.S. Food and Drug Administration’s efforts to regulate stem cell therapies.
In the News
September 1, 2017
Bloomberg BNA | Experts Laud FDA’s Stepped-Up Stem Cell Efforts
Media Contact